Amicus Therapeutics Becomes Oversold (FOLD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of Amicus Therapeutics Inc ( FOLD) entered into oversold territory, hitting an RSI reading of 26.3, after changing hands as low as $6.07 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 36.4. A bullish investor could look at FOLD's 26.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of FOLD shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Amicus Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, FOLD's low point in its 52 week range is $4.98 per share, with $11.78 as the 52 week high point — that compares with a last trade of $6.12.

If you liked this article you might like

Remember, Fed News Is a Trigger for the Computers

Strong Action in Individual Stocks Starts to Feel a Bit Frothy

The Flippers Are at Work and the Bears Are Hopeful

Portola Shares Lower After Pricing Stock Offering - Biotech Movers

Time to Bring Amicus Therapeutics Into the 'FOLD'